Camp4 Therapeutics

Camp4 Therapeutics company information, Employees & Contact Information

Updated June 2026

Quick answer

Camp4 Therapeutics is a Biotechnology Research company and founded in 2016. It has approximately 64 employees on record. Contact data was last refreshed in June 2026. Find Camp4 Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

At CAMP4 Therapeutics, we are pioneering a novel approach to programmable therapeutics. We combine a deep understanding of regulatory RNA and gene expression with a complementary and customizable oligonucleotide modality. Our platform’s proprietary insights enable us to harness the power of RNA to upregulate the expression of genes and unlock the potential to create treatments for hundreds of diseases affecting millions of patients. Join us at the forefront.

Company Details

Employees
64
Founded
2016
Address
1 Kendall Sq, Cambridge,massachusetts 02139,united States
Email
in****@****4tx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Cambridge, Massachusetts
Looking for a particular Camp4 Therapeutics employee's phone or email?

Camp4 Therapeutics Questions

News

CAMP4 Announces an Oversubscribed Private Placement of up - GlobeNewswire

CAMP4 Announces an Oversubscribed Private Placement of up GlobeNewswire

CAMP4 Therapeutics Promotes Kelly Gold to Chief Financial Officer - citybiz

CAMP4 Therapeutics Promotes Kelly Gold to Chief Financial Officer citybiz

CAMP4 Therapeutics to Present at Piper Sandler Healthcare Conference in NYC - Stock Titan

CAMP4 Therapeutics to Present at Piper Sandler Healthcare Conference in NYC Stock Titan

Gene Identification Market Size, Report by 2034 - Precedence Research

Gene Identification Market Size, Report by 2034 Precedence Research

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th - GlobeNewswire

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th GlobeNewswire

About Us - Great American Insurance Group - Specialty Property & Casualty Insurance - FinancialContent

About Us - Great American Insurance Group - Specialty Property & Casualty Insurance FinancialContent

CAMP4 Enters Strategic Research Collaboration to Advance - GlobeNewswire

CAMP4 Enters Strategic Research Collaboration to Advance GlobeNewswire

Top Camp4 Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant